Role of Hypouricemic Agents in Tumor Lysis Syndrome: A Meta-Analysis
Waleed Alshehri, Abdulrahman Aljohani, Reem Alhasani, Anood Alshammari, Jwael A. Alhamoud, Atheer Alruwaili, Omniah Altemani, Ali Bahabri, Hassan Alahmadi, Shaykhah Alderaan, Afnan Almutairi, Marwan Alsehli, Mohammed Almohammadi, Faisal Almaleki & Hamoud Alotaibi · Journal of Pharmaceutical Research International · 2021
Objective and background: Tumor lysis syndrome (TLS) is a life-threatening emergency and demands emergency care of effective outcome with minimal or no side effects. The Hypouricemic agents, including Rasburicase, Allopurinol and Febuxostate used for the management of TLS. This s...
Open access
Research Article
10.9734/jpri/2021/v33i33A31785